DNA levels at baseline and during treatment predict response and progression free survival in advanced breast cancer, ...
Post hoc analysis of the CLEAR study in advanced renal cell carcinoma (RCC): Effect of subsequent therapy on survival outcomes in the lenvatinib (LEN) + everolimus (EVE) versus sunitinib (SUN) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results